S-adenosyl methionine (SAMe) augmentation in major depressive disorder - PubMed (original) (raw)
Editorial
S-adenosyl methionine (SAMe) augmentation in major depressive disorder
J Craig Nelson. Am J Psychiatry. 2010 Aug.
No abstract available
Comment on
- S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. Papakostas GI, et al. Am J Psychiatry. 2010 Aug;167(8):942-8. doi: 10.1176/appi.ajp.2009.09081198. Epub 2010 Jul 1. Am J Psychiatry. 2010. PMID: 20595412 Clinical Trial.
Similar articles
- S-Adenosyl Methionine (SAMe) for Depression in Adults.
Wilson A. Wilson A. Issues Ment Health Nurs. 2019 Aug;40(8):725-726. doi: 10.1080/01612840.2017.1392161. Epub 2019 Jan 11. Issues Ment Health Nurs. 2019. PMID: 30633610 Review. No abstract available. - Discrepancy in response and remission rates for SAMe-treated patients in a double-blind, randomized clinical trial.
Fleisch SB, Travis MJ, Ryan ND. Fleisch SB, et al. Am J Psychiatry. 2010 Dec;167(12):1533; author reply 1533. doi: 10.1176/appi.ajp.2010.10091252. Am J Psychiatry. 2010. PMID: 21131413 No abstract available. - S-adenosyl-methionine in depression: a comprehensive review of the literature.
Papakostas GI, Alpert JE, Fava M. Papakostas GI, et al. Curr Psychiatry Rep. 2003 Dec;5(6):460-6. doi: 10.1007/s11920-003-0085-2. Curr Psychiatry Rep. 2003. PMID: 14609501 Review. - S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial.
Papakostas GI, Mischoulon D, Shyu I, Alpert JE, Fava M. Papakostas GI, et al. Am J Psychiatry. 2010 Aug;167(8):942-8. doi: 10.1176/appi.ajp.2009.09081198. Epub 2010 Jul 1. Am J Psychiatry. 2010. PMID: 20595412 Clinical Trial. - Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP, Mischoulon D, Tedeschini E, Goodness T, Cohen LS, Fava M, Papakostas GI. Freeman MP, et al. J Clin Psychiatry. 2010 Jun;71(6):682-8. doi: 10.4088/JCP.10r05976blu. J Clin Psychiatry. 2010. PMID: 20573327
Cited by
- S-adenosyl methionine (SAMe) for depression in adults.
Galizia I, Oldani L, Macritchie K, Amari E, Dougall D, Jones TN, Lam RW, Massei GJ, Yatham LN, Young AH. Galizia I, et al. Cochrane Database Syst Rev. 2016 Oct 10;10(10):CD011286. doi: 10.1002/14651858.CD011286.pub2. Cochrane Database Syst Rev. 2016. PMID: 27727432 Free PMC article. Review. - S-adenosylmethionine in liver health, injury, and cancer.
Lu SC, Mato JM. Lu SC, et al. Physiol Rev. 2012 Oct;92(4):1515-42. doi: 10.1152/physrev.00047.2011. Physiol Rev. 2012. PMID: 23073625 Free PMC article. Review. - Major depressive disorder: new clinical, neurobiological, and treatment perspectives.
Kupfer DJ, Frank E, Phillips ML. Kupfer DJ, et al. Lancet. 2012 Mar 17;379(9820):1045-55. doi: 10.1016/S0140-6736(11)60602-8. Epub 2011 Dec 19. Lancet. 2012. PMID: 22189047 Free PMC article. Review. - Possible directions for the discovery of new antidepressant treatments.
Young SN. Young SN. J Psychiatry Neurosci. 2011 Jan;36(1):3-5. doi: 10.1503/jpn.100169. J Psychiatry Neurosci. 2011. PMID: 21167108 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical